341 related articles for article (PubMed ID: 10525320)
1. Impaired production of IL-12 in systemic lupus erythematosus. III: deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression.
Liu TF; Jones BM; Wong RW; Srivastava G
Cytokine; 1999 Oct; 11(10):805-11. PubMed ID: 10525320
[TBL] [Abstract][Full Text] [Related]
2. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
3. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit.
Snijders A; Hilkens CM; van der Pouw Kraan TC; Engel M; Aarden LA; Kapsenberg ML
J Immunol; 1996 Feb; 156(3):1207-12. PubMed ID: 8557999
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of interleukin-23 subunits in human peripheral blood mononuclear cells and hematopoietic cell lines in response to various inducers.
Ma XT; Zhang XJ; Zhang B; Geng YQ; Lin YM; Li G; Wu KF
Cell Biol Int; 2004; 28(10):689-97. PubMed ID: 15516327
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
[TBL] [Abstract][Full Text] [Related]
7. Differential response of the murine IL-12 p35 gene to lipopolysaccharide compared with interferon-gamma and CD40 ligation.
Vaidyanathan H; Gentry JD; Weatherman A; Schwartzbach SD; Petro TM
Cytokine; 2001 Oct; 16(1):1-9. PubMed ID: 11669581
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human IL-18 mRNA expression.
Marshall JD; Aste-Amézaga M; Chehimi SS; Murphy M; Olsen H; Trinchieri G
Clin Immunol; 1999 Jan; 90(1):15-21. PubMed ID: 9884348
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 production by human polymorphonuclear leukocytes.
Cassatella MA; Meda L; Gasperini S; D'Andrea A; Ma X; Trinchieri G
Eur J Immunol; 1995 Jan; 25(1):1-5. PubMed ID: 7843218
[TBL] [Abstract][Full Text] [Related]
10. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
[TBL] [Abstract][Full Text] [Related]
11. Thiol antioxidants inhibit the formation of the interleukin-12 heterodimer: a novel mechanism for the inhibition of IL-12 production.
Mazzeo D; Sacco S; Di Lucia P; Penna G; Adorini L; Panina-Bordignon P; Ghezzi P
Cytokine; 2002 Mar; 17(6):285-93. PubMed ID: 12061835
[TBL] [Abstract][Full Text] [Related]
12. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
[TBL] [Abstract][Full Text] [Related]
13. Control of cytokine gene expression using small RNA interference: blockade of interleukin-10 and interferon-gamma gene expression in pig cells.
Sidahmed AM; Wilkie BN
Vet Immunol Immunopathol; 2007 May; 117(1-2):86-94. PubMed ID: 17368795
[TBL] [Abstract][Full Text] [Related]
14. Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE.
Liu TF; Jones BM
Cytokine; 1998 Feb; 10(2):148-53. PubMed ID: 9512905
[TBL] [Abstract][Full Text] [Related]
15. High levels of TH2 cytokine gene expression in systemic lupus erythematosus.
Richaud-Patin Y; Alcocer-Varela J; Llorente L
Rev Invest Clin; 1995; 47(4):267-72. PubMed ID: 8525128
[TBL] [Abstract][Full Text] [Related]
16. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
17. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
Rook AH; Kubin M; Cassin M; Vonderheid EC; Vowels BR; Wolfe JT; Wolf SF; Singh A; Trinchieri G; Lessin SR
J Immunol; 1995 Feb; 154(3):1491-8. PubMed ID: 7822812
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
Shah D; Kiran R; Wanchu A; Bhatnagar A
Immunol Lett; 2010 Mar; 129(1):7-12. PubMed ID: 20105444
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11 inhibits macrophage interleukin-12 production.
Leng SX; Elias JA
J Immunol; 1997 Sep; 159(5):2161-8. PubMed ID: 9278303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
